ArticleBlood cancer journal2019

The ALK inhibitor AZD3463 effectively inhibits growth of sorafenib-resistant acute myeloid leukemia.

Sausan A Moharram et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.